Drug Studies America   Report issue

For profit Phase 2 Phase 3
Founded: Marietta GA United States (2010)

Organization Overview

First Clinical Trial
2010
NCT00813813
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Alternative names

Drug Study America

Active Ingredients

Drugs in Phase 3 Trials (1)

diclofenac (voltaren) (2 trials)

Drugs in Phase 2 Trials (1)

recombinant human gdf-5 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Intervertebral Disc Degeneration (Phase 2)

Osteoarthritis (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 2